These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20356394)

  • 1. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.
    Sanders AM; Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Monjazeb AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2010 Mar; 10():121. PubMed ID: 20356394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice.
    Hicks AM; Willingham MC; Du W; Pang CS; Old LJ; Cui Z
    Cancer Immun; 2006 Oct; 6():11. PubMed ID: 17073402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.
    Riedlinger G; Adams J; Stehle JR; Blanks MJ; Sanders AM; Hicks AM; Willingham MC; Cui Z
    BMC Cancer; 2010 May; 10():179. PubMed ID: 20438640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.
    Shiloh MU; MacMicking JD; Nicholson S; Brause JE; Potter S; Marino M; Fang F; Dinauer M; Nathan C
    Immunity; 1999 Jan; 10(1):29-38. PubMed ID: 10023768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular cancer resistance of the SR/CR mouse.
    Koch J; Hau J; Jensen HE; Nielsen CH; Rieneck K
    APMIS; 2012 Dec; 120(12):974-87. PubMed ID: 23030360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.
    Hicks AM; Riedlinger G; Willingham MC; Alexander-Miller MA; Von Kap-Herr C; Pettenati MJ; Sanders AM; Weir HM; Du W; Kim J; Simpson AJ; Old LJ; Cui Z
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7753-8. PubMed ID: 16682640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
    Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
    Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the cancer-resistant phenotype in SR/CR mice and the effect of litter seriation.
    Koch J; Boschian A; Hau J; Rieneck K
    In Vivo; 2008; 22(5):565-9. PubMed ID: 18853747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice.
    Ambs S; Ogunfusika MO; Merriam WG; Bennett WP; Billiar TR; Harris CC
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8823-8. PubMed ID: 9671763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase.
    Banerjee R; Anguita J; Fikrig E
    Infect Immun; 2000 Jul; 68(7):4361-2. PubMed ID: 10858261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cells from SR/CR mice induce the regression of established tumors in BALB/c and C57BL/6 mice.
    Koch J; Hau J; Pravsgaard Christensen J; Elvang Jensen H; Bagge Hansen M; Rieneck K
    PLoS One; 2013; 8(3):e59995. PubMed ID: 23555858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages.
    Wiese M; Gerlach RG; Popp I; Matuszak J; Mahapatro M; Castiglione K; Chakravortty D; Willam C; Hensel M; Bogdan C; Jantsch J
    Infect Immun; 2012 Apr; 80(4):1455-66. PubMed ID: 22252868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Nitric Oxide-mediated β2 Integrin Inhibition of Neutrophils.
    Bhopale VM; Yang M; Yu K; Thom SR
    J Biol Chem; 2015 Jul; 290(28):17474-84. PubMed ID: 26032418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.
    Davie SA; Maglione JE; Manner CK; Young D; Cardiff RD; MacLeod CL; Ellies LG
    Transgenic Res; 2007 Apr; 16(2):193-201. PubMed ID: 17206489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.
    Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Sanders AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2009 Sep; 9():328. PubMed ID: 19754973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
    Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
    J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative burst and neutrophil elastase contribute to clearance of Aspergillus fumigatus pneumonia in mice.
    Prüfer S; Weber M; Stein P; Bosmann M; Stassen M; Kreft A; Schild H; Radsak MP
    Immunobiology; 2014 Feb; 219(2):87-96. PubMed ID: 24054721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
    Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
    Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.